Abstract
The antibiotic 2'-deoxycoformycin, a potent inhibitor of adenosine deaminase, has potential as a chemotherapeutic agent. Injection of 2'-deoxycoformycin i.v. (0.2 mg/kg) to mice bearing ascites L1210 leukemia cells completely inhibits adenosine deaminase in both erythrocytes and L1210 cells. The recovery of the enzymic activity is markedly different in the two tissues. The recovery is very slow in erythrocytes (13% in 48 hr), whereas 80% recovery occurs during the same time interval in L1210 cells. This marked difference in the recovery of the enzyme in different tissues may play a role in the pharmacological and chemotherapeutic behavior of this drug.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1425-1427 |
| Number of pages | 3 |
| Journal | Cancer Research |
| Volume | 39 |
| Issue number | 4 |
| State | Published - Apr 1979 |
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint Dive into the research topics of 'Recovery of 2'-Deoxycoformycin-inhibited Adenosine Deaminase of Mouse Erythrocytes and Leukemia L1210 in Vivo'. Together they form a unique fingerprint.
Cite this
Agarwal, R. P. (1979). Recovery of 2'-Deoxycoformycin-inhibited Adenosine Deaminase of Mouse Erythrocytes and Leukemia L1210 in Vivo. Cancer Research, 39(4), 1425-1427.